BSD Medical Reports Terumo Europe N.V. Obtains Regulatory Approvals for Marketing MicroThermX® Microwave Ablation System in Additional Countries

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today reported that Terumo Europe NV (Terumo) has obtained approvals to market and import the MicroThermX® Microwave Ablation System (MicroThermX) in South Africa, Dubai, Qatar, and Jordan. These approvals are part of Terumo’s comprehensive marketing strategy to expand MicroThermX distribution outside of Western Europe. BSD’s exclusive, multi-million dollar agreement with Terumo covers distribution of the MicroThermX in more than 100 countries, including Europe, Western Asia and Africa, with a market potential that exceeds $1 billion.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC